Apolipoprotein E polymorphism modulates the association between obesity and dyslipidemias during young adulthood: The Bogalusa Heart Study

Metabolism: Clinical and Experimental

Volumn 50, Issue 6, 2001, Pages 696-702

  Srinivasan, S R ^a   Ehnholm, C ^a   Elkasabany, A ^a   Berenson, G S ^a  

^a Tulane Center for Cardiovascular Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ADULTHOOD; ALLELE; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GENE LOCUS; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; INCIDENCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034971458     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2001.23299     Document Type: Article

References (56)

1. Apolipoprotein E polymorphism and atherosclerosis
2. Apolipoprotein E polymorphism in health and disease
3. Apolipoprotein E alleles and risk of coronary disease: A meta-analysis
4. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinemia in man
5. Human isoprotein subclasses are genetically determined
6. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site
7. The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B-containing lipoprotein in humans
8. Isoprotein specificity in the hepatic uptake of apolipoprotein E and the pathogenesis of dysbetalipoproteinemia
9. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E
10. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype
11. Metabolism of apolipoprotein B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia
12. Resistance of a very-low-density lipoprotein subpopulation from familial dysbetalipoproteinemia to in vitro lipolytic conversion of the low-density lipoprotein fractions
13. Role of apolipoprotein E in the lipolytic conversion of very-low-density lipoproteins to low-density lipoproteins in type III hyperlipoproteinemia
14. Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype
15. Apolipoprotein E polymorphism in the Finnish population: Gene frequencies and relation to lipoprotein concentrations
16. The use of measured genotype information in the analysis of quantitative phenotypes in man: II. The role of the apolipoprotein E polymorphism in determining levels, variability and covariability of cholesterol, betalipoprotein and triglycerides in a sample of unrelated individuals
17. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms
18. The apolipoprotein E polymorphism: A comparison of allele frequencies and effects in nine populations
19. Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low-density lipoprotein cholesterol in Hispanics and non-Hispanic whites
20. Apolipoprotein E polymorphism and its association with serum lipoprotein concentrations in black versus white children: The Bogalusa Heart Study
21. Apolipoprotein E affects serial changes in total and low-density lipoprotein cholesterol in adolescent girls: Project HeartBeat
22. Modulation of plasma triglyceride levels by apoE phenotype: A meta-analysis
23. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study
24. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study
25. Evidence that the apolipoprotein E genotype effects on lipid levels can change with age in males: A longitudinal analysis
26. Weight gain and serum triglycerides in normal men
27. Obesity and lipoprotein cholesterol in the Framingham Offspring Study
28. Relationships of measurements of body mass to plasma lipoproteins in school children and adults
29. Increasing impact of obesity on serum lipids and lipoproteins in young adults: The Bogalusa Heart Study
30. An analysis of genotype effects and their interactions by using the apolipoprotein E polymorphism and longitudinal data
31. Association of apolipoprotein epsilon 4 allele with hypertriglyceridemia in obesity
32. Apolipoprotein E polymorphism and hyperlipoproteinemia in obesity
33. Apolipoprotein E polymorphism alters the association between body fatness and plasma lipoproteins in women
34. The gender-specific apolipoprotein E genotype influence on the distribution of plasma lipids and apolipoproteins in the population of Rochester, Minnesota. II. Regression relationships with concomitants
35. Relationship between obesity and serum lipoproteins in children with different apolipoprotein E phenotypes: The Bogalusa Heart Study
36. Apolipoprotein E phenotype modifies metabolic and hemodynamic abnormalities related to central obesity in women
37. Interaction between lifestyle-related factors and the apoE polymorphism on plasma lipid and apolipoproteins. The EARS Study
38. The Bogalusa Heart Study: 20th Anniversary Symposium
39. Serum lipoproteins in children and methods for study
40. Apolipoprotein E phenotypes in Finnish youths: A cross-sectional and 6-year follow-up study
41. A rapid micromethod for apolipoprotein E phenotyping directly in serum
42. Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study
43. The general relationship between average effect and average excess
44. Influence of apolipoprotein E polymorphism on serum lipids and lipoprotein changes from childhood to adulthood. The Bogalusa Heart Study
45. The effect of the apolipoprotein E phenotype on plasma lipids is not influenced by environmental variability: Result of a Dutch twin study
46. Impact of gender, apolipoprotein E phenotypes, and diet on serum lipids and lipoproteins in infancy
47. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study
48. Influence of apolipoprotein E polymorphism on the tracking of childhood levels of serum lipids and apolipoproteins over a 6-year period. The Bogalusa Heart Study
49. Transport of very-low-density lipoprotein triglycerides in varying degrees of obesity and hypertriglyceridemia
50. Increased low-density lipoprotein production associated with obesity
51. Obesity and lipid metabolism: Relevance of body fat distribution
52. Plasma high-density lipoprotein concentration and subfraction distribution in relation to triglyceride metabolism
53. Plasma high density lipoproteins: Metabolism and relationship to atherogenesis
54. Absolute fat mass, percent body fat, and body-fat distribution: Which is the real determinant of blood pressure and serum glucose?
55. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: The Bogalusa Heart Study
56. Secular increases in relative weight and adiposity among children over two decades: The Bogalusa Heart Study